These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25737474)

  • 1. The Comparison of Thyroarytenoid Muscle Myectomy and Type II Thyroplasty for Spasmodic Dysphonia.
    Nomoto M; Tokashiki R; Hiramatsu H; Konomi U; Motohashi R; Sakurai E; Toyomura F; Ueda Y; Inoue S; Tsukahara K; Suzuki M
    J Voice; 2015 Jul; 29(4):501-6. PubMed ID: 25737474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
    Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arytenoid adduction with nerve-muscle pedicle transfer vs arytenoid adduction with and without type I thyroplasty in paralytic dysphonia.
    Hassan MM; Yumoto E; Sanuki T; Kumai Y; Kodama N; Baraka MA; Wahba H; Hafez NG; El-Adawy AA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):833-9. PubMed ID: 25123168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative complications and safety of type II thyroplasty (TPII) for adductor spasmodic dysphonia.
    Mizoguchi K; Hatakeyama H; Yanagida S; Nishizawa N; Oridate N; Fukuda S; Homma A
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2215-2223. PubMed ID: 28229294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
    Kosztyła-Hojna B; Berger G; Zdrojkowski M
    Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Evaluation of Type 2 Thyroplasty with Titanium Bridges for Adductor Spasmodic Dysphonia.
    Sanuki T; Yumoto E
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):80-84. PubMed ID: 28463639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of type II thyroplasty on adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Minoda R; Kodama N
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):540-6. PubMed ID: 20304275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
    Su CY; Lai CC; Wu PY; Huang HH
    Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.
    Koufman JA; Rees CJ; Halum SL; Blalock D
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):97-102. PubMed ID: 16514790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective.
    Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM
    Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voice tuning with new instruments for type II thyroplasty in the treatment of adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Toya Y; Kumai Y
    Auris Nasus Larynx; 2016 Oct; 43(5):537-40. PubMed ID: 26811303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment for adductor spasmodic dysphonia--efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy.
    Nakamura K; Muta H; Watanabe Y; Mochizuki R; Yoshida T; Suzuki M
    Acta Otolaryngol; 2008; 128(12):1348-53. PubMed ID: 18607929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.
    Tsuji DH; Chrispim FS; Imamura R; Sennes LU; Hachiya A
    Braz J Otorhinolaryngol; 2006; 72(2):261-6. PubMed ID: 16951863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral Posterior Cricoarytenoid Myoneurectomy for Abductor Spasmodic Dysphonia.
    Benito DA; Ferster APO; Sataloff RT
    J Voice; 2020 Jan; 34(1):127-129. PubMed ID: 30174222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
    van Esch BF; Wegner I; Stegeman I; Grolman W
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective lateral laser thyroarytenoid myotomy for adductor spasmodic dysphonia.
    Hussain A; Shakeel M
    J Laryngol Otol; 2010 Aug; 124(8):886-91. PubMed ID: 20426891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spasmodic Dysphonia].
    Tokashiki R
    Brain Nerve; 2023 Jan; 75(1):15-22. PubMed ID: 36574969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia.
    Sanuki T; Takemoto N
    Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.